Blinded statin trials supported few additional side effects listed on labels
Most additional effects on statin labels lacked support in blinded trials; liver-test abnormalities, urine changes and swelling did increase.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
These blinded trials supported few additional side effects attributed to statins on product labels. They found increases in liver-test abnormalities, urine composition changes and swelling, separately from previously reported muscle and diabetes effects. Most other listed conditions lacked support for a causal link, although this does not prove that individual reactions are impossible.
The abstract does not detail every condition assessed or the clinical consequences of abnormal liver tests. This brief cannot evaluate those missing details.
What researchers found
Abnormal liver enzyme (transaminase) events
Statin versus placebo over median 4·5 years. The event rate was 1·41 times the placebo rate; the 95% confidence interval, 1·26–1·57, shows uncertainty around that relative estimate.
How effects were checked
Researchers collected adverse-effect terms from medicine labels and assessed them using blinded trial data. Their analysis accounted for testing many outcomes, limiting the chance of treating a chance result as convincing evidence.
Comparing statin intensity
More intensive statin regimens also produced more liver-test abnormalities than less intensive regimens. Urine changes and swelling did not show statistically significant increases in that comparison; this does not establish that the regimens were equivalent.
The original publication
Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials.
Cholesterol Treatment Trialists' (CTT) Collaboration. Electronic address: [email protected], Cholesterol Treatment Trialists' (CTT) Collaboration
Lancet · 2026
- PubMed ID
- 41655587
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.